In lung cancer cells, the miRNAs responsible for the inhibitory effects of withaferin A were investigated, and the treatment with withaferin A caused an upregulation of the pro-apoptotic molecules, p53 and Bax, but reduced the activity of Bcl-2. Here, BAX is linked to lung cancer.